📰 Prospective Study News
Page 5 - Prospective Study News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prospective Study. Real-time updates on events, politics, business and more.
January 26, 2023
RedHill Receives USPTO Notice of Allowance for a Patent Covering Phase 3-stage RHB-204 for the Treatment of NTM Disease - read this article along with other careers information, tips and advice on BioSpace
January 19, 2023
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...
January 19, 2023
Palatin Initiates Enrollment in the Phase 2 Bremelanotide BREAKOUT Study in Patients with Diabetic Kidney Disease - read this article along with other careers information, tips and advice on BioSpace
December 20, 2022
Milwaukee, WI (PRWEB) December 20, 2022 -- AAEA invites media to attend their sessions at the ASSA 2023 Annual Meeting in New Orleans. On Friday, January 6,
December 13, 2022
Agilent Technologies Inc. announced today that the U.S. Food and Drug Administration has approved Agilent Resolution ctDx FIRST as a companion diagnostic to identify advanced... | December 12, 2022
December 13, 2022
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) announced today that the U.S. Food and Drug Administration (FDA) has approved Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations who may benef...
November 27, 2022
Daily Express is the sister paper of Overseas Chinese Daily News (OCDN). It was founded by the late Tan Sri Yeh Pao Tzu and the first issue hit the streets on March 1, 1963. Published in trilingual ie English, Bahasa Malaysia and Kadazan, it is by far the largest circulation daily newspaper in Sabah.
November 2, 2022
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
November 2, 2022
The second round of late-breaking clinical trial results were presented at VIVA22 on Nov. 1 in Las Vegas, NV.
November 1, 2022
Gilead to Present Data Across Viral Hepatitis and Liver Fibrosis at The Liver Meeting® 2022, Reinforcing Gilead as a Leader in Addressing Treatment Needs for People Living With Liver Disease